Anteris Technologies Global (NASDAQ:AVR) Reaches New 52-Week High – Still a Buy?

Shares of Anteris Technologies Global Corp. (NASDAQ:AVR) reached a new 52-week high during trading on Monday . The stock traded as high as $10.67 and last traded at $10.9070, with a volume of 819636 shares. The stock had previously closed at $10.24.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 price objective on shares of Anteris Technologies Global in a research note on Friday, March 27th. Barclays increased their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Wall Street Zen upgraded shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Wells Fargo & Company initiated coverage on Anteris Technologies Global in a research report on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 price target on the stock. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $16.00.

Anteris Technologies Global Price Performance

The firm has a market capitalization of $1.06 billion, a P/E ratio of -4.89 and a beta of 1.65. The company’s 50-day simple moving average is $8.46 and its two-hundred day simple moving average is $6.64.

Anteris Technologies Global (NASDAQ:AVR) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The business had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.77 million. During the same quarter last year, the firm earned ($0.61) EPS. Analysts predict that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Susan Elizabeth Knight bought 11,000 shares of Anteris Technologies Global stock in a transaction on Tuesday, June 2nd. The stock was purchased at an average cost of $9.29 per share, with a total value of $102,190.00. Following the purchase, the director directly owned 11,000 shares of the company’s stock, valued at approximately $102,190. This trade represents a ? increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 4.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Anteris Technologies Global

Several institutional investors have recently bought and sold shares of AVR. Militia Capital Management LLC purchased a new position in shares of Anteris Technologies Global in the 1st quarter valued at approximately $3,663,000. Perceptive Advisors LLC lifted its holdings in shares of Anteris Technologies Global by 104.4% during the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock worth $19,011,000 after acquiring an additional 1,750,000 shares during the last quarter. Avidity Partners Management LP purchased a new stake in shares of Anteris Technologies Global in the first quarter worth $832,000. Bank of America Corp DE increased its holdings in shares of Anteris Technologies Global by 12.6% in the first quarter. Bank of America Corp DE now owns 68,755 shares of the company’s stock valued at $382,000 after purchasing an additional 7,688 shares during the period. Finally, Anson Funds Management LP acquired a new position in shares of Anteris Technologies Global during the first quarter worth about $1,126,000.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.